Omecamtiv Mecarbil: A Novel Mechanistic and Therapeutic Approach to Chronic Heart Failure Management
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference50 articles.
1. Epidemiology of heart failure;Roger VL;Circulation Res,2013
2. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association;Heidenreich P;Circ Heart Fail,2013
3. Reply: BAG3 protein in advanced-stage heart failure;Storrow AB;JACC: Heart Failure,2014
4. The epidemiology of heart failure: the Framingham Study;Ho KK;J Am Coll Cardiol,1993
5. Epidemiology of diastolic heart failure;Owan TE;Prog Cardiovasc Dis,2005
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Magnetic nanoparticles and their hybrid biomaterials for drug delivery and theranostic applications in cardiovascular diseases;Journal of Drug Delivery Science and Technology;2024-06
2. Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry;PLOS ONE;2024-05-24
3. Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future;Frontiers in Cardiovascular Medicine;2024-03-19
4. Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium;International Journal of Molecular Sciences;2024-03-07
5. Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction;Life;2023-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3